Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
68 hedge funds and large institutions have $404M invested in Oxford Immunotec Global PLC Ordinary Shares in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 24 reducing their positions, and 15 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
8% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 24
2% less capital invested
Capital invested by funds: $411M → $404M (-$6.75M)
7% less funds holding
Funds holding: 73 → 68 (-5)
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
+$6.19M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$5.87M |
| 3 |
New York State Common Retirement Fund
Albany,
New York
|
+$4.65M |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$3.71M |
| 5 |
FA
Friess Associates
Greenville,
Delaware
|
+$3.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$9.95M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$9.6M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$8.14M |
| 4 |
Man Group
London,
United Kingdom
|
-$6.06M |
| 5 |
FI
Fosun International
Hong Kong,
China
|
-$2.29M |
OXFD Hedge Fund Activity: Q4 2019 in Review
68 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q4 2019, worth a combined $404M — down 1.6% from $411M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of OXFD and 11 opened new positions — a net loss of 4 holders — while 24 trimmed existing stakes and 26 added.
The largest buyer was Penn Capital Management, adding an estimated $6.19M. The largest seller was Millennium Management, cutting an estimated $9.95M.
- 68 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q4 2019, down from 73 in Q3 2019.
- Funds reported $404M of Oxford Immunotec Global PLC Ordinary Shares stock for Q4 2019, down 1.6% quarter-over-quarter.
- 11 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q4 2019 and 15 closed out, a net change of -4 holders.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q4 2019 was Penn Capital Management, an estimated $6.19M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q4 2019 was Millennium Management, an estimated $9.95M sold.
Based on aggregated 13F filings for Q4 2019.